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Abstract: Dendritic cells (DC) play a pivotal role in the initiation of T-cell-mediated immune responses, making them an 
attractive cellular adjuvant for use in cancer vaccines. The interaction of T cells with DC is crucial for directing T cell 
differentiation towards the Th1, Th2 or Th17 type, and several factors determining the direction of the T cell polarization. 
IL-12 plays a central role in the immune system, not only by augmenting the cytotoxic activity of T cells and NK cells and 
regulating IFN-γ production, but also by the capacity of IL-12 to promote the development of Th1 cells. Therefore, it is 
important to identify factors that might affect the differentiation, maturation and function of DC. Ginseng is a medicinal 
herb widely used in Asian countries, and many of its pharmacological actions are attributed to the ginsenosides. Moreover, 
T-cadinol and calamenene are sesquterpenes isolated from the heartwood of Cryptomeria japonica being pharmacologically 
active substances. We investigated whether M1 and M4, end products of steroidal ginseng saponins metabolized in digestive 
tracts, as well as T-cadinol and calamenene can drive DC maturation from human monocytes in vitro. Human monocytes 
were cultured with GM-CSF and IL-4 for 6 days under standard conditions, followed by another 2 days in the presence of 
M1, M4, T-cadinol or calamenene. The expression levels of CD1a, CD80, CD83, CD86 and HLA-DR on M1-primed DC, 
M4-primed DC, T-cadinol-primed DC and calamenene-primed DC were enhanced with a concomitant decrease in endocytic 
activity. M1-primed DC, M4-primed DC, T-cadinol-primed DC or calamenene-primed DC enhanced the T cell stimulatory 
capacity in an allo MLR (allogeneic mixed lymphocyte reaction). Naïve T cells co-cultured with allogeneic M1-primed DC, 
M4-primed DC, T-cadinol-primed DC or calamenene-primed DC turned into typical Th1 cells, which produced large quan-
tities of IFN-γ and released small amounts of IL-4 depending on IL-12 secretion. In the CTL assay (cytotoxic T-lymphocyte 
assay), the production of IFN-γ and 
51Cr release on M4-primed DC was more augmented than of immature DC or TNF-α-
primed DC. These results suggest that M1, M4, T-cadinol and calamenene appear to be a good factor to induce DC maturation, 
or even better in some respect, for the use in clinical DC therapy to induce strong Th1 type immune responses.
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Introduction
Dendritic cells (DC) are considered to be the principal antigen presenting cells (APC), whose main func-
tion is to identify microbial structures and present these to naïve T cells in the lymph node [1–3] and 
clinical application of DC has been initiated as a cellular immunotherapy against cancer [4]. DC are 
generated from either myeloid or lymphoid bone marrow progenitors through intermediate DC precur-
sors that home to sites of potential antigen entry, where they differentiate locally into immature DC. After 
antigen capture in the presence of maturation signals associated with inﬂ  ammation or infection, immature 
DC are activated by TLRs, interferon’s (IFNs), or members of TNF-R family and undergo a complex 
maturation process. This process in vivo is paralleled by migration of DC to T cell-rich areas of lymphoid 
organs, where they present antigen-derived peptides to antigen-speciﬁ  c T-cells and direct their differen-
tiation into T effector or memory cells [5]. The interaction of T cells with DC is crucial for directing 
T cell differentiation towards the Th1, Th2 or Th17 type and several factors determine the direction of 
T cell polarization [6–12]. Human-monocytes-derived DC matured by either interferon-alpha (IFN-α), 
tumor necrosis factor-alpha (TNF-α) or LPS in vitro produce high levels of IL-12 and induce Th1 cells 
[13–15]. Th1 responses predominate in organ-speciﬁ  c autoimmune disorders, acute allograft rejection 
and in some chronic inﬂ  ammatory disorders [16] and Th2 responses predominate on Omenn’s syndrome, 
transplantation tolerance, chronic graft-versus-host disease and allergic diseases [17]. Th17 cells comprise 270
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a recently identiﬁ  ed Th-cell lineage that has a 
pro-inﬂ  ammatory role in autoimmunity and tissue 
inﬂ  ammatory [18]. One of the most important goal 
of DC research is the development of DC-based 
strategies for enhancing immune responses against 
tumors and infectious agents. A variety of prepara-
tions of DC can stimulate anti-tumor immunity, 
including DC loaded with proteins, DC fused with 
tumor cells and DC transduced with tumor-derived 
DNA or viral vectors. Analyses of the clinical 
results suggest that the maturation status of DC used 
in such protocols greatly affects the immune 
response that follows the treatments. Thus, for 
immunotherapeutic applications, it appears crucial 
to identify factors that might affect the differentia-
tion, maturation, and function of DC. Therefore, it 
is important to identify factors that might affect the 
differentiation, maturation and function of DC.
The root of Panax ginseng C.A. Meyer has been 
widely and well used as an important of many 
Chinese prescriptions called “Kan-Pou medicine” 
for more than 2000 years and is now well known 
as CAM (complementary and alternative medicine) 
throughout the world. Recently, some reports have 
shown that the ginseng and its major component 
(saponins) ameliorate the symptoms and the lesions 
evoked by stress (anti-stress action), for example, 
improvements in gastrointestinal symptoms 
(anorexia, dyspepsia, etc.), gastric ulcer, fatigue, 
boredom, anxiety and essential hypertension in 
stressed animals and human [19–21]. Moreover, 
Yun [22] has shown that the prolonged administra-
tion of ginseng extract signiﬁ  cantly inhibited the 
incidence of hepatoma and also proliferation of 
pulmonary tumors induced by aﬂ  atoxin B1 and 
urethane. It has been learned that the ginsenosides 
in ginseng are metabolized by gastric acid and by 
enzymes in intestinal bacteria when they are orally 
administered [23, 24]. The sugar moieties of sapo-
nins are in turn hydrolyzed in the digestive tracts. 
The ginsenosides are classiﬁ  ed in three groups, the 
protopanaxadiol, the protopanaxatriol and the 
oleanoic acid groups, on the basis of the chemical 
structures of their aglycones. Most of the ginsen-
osides belong to the protopanaxa-type (steroidal 
saponins), and the major metabolites of ginseng 
including the intermediates are M1, M2, M3, M5 
and M12 derived from the protopanaxadiols and 
are M4 and M11 from the protopanaxatriols. We 
have recently reported that M4 inhibited the ACh-
induced secretion of catecholamines from bovine 
adrenal chromafﬁ  n cells and this inhibition was 
due to the blockade of Na
+inﬂ  ux through nicotinic 
ACh receptor-operated cation channels [25]. Thus, 
ginseng saponin metabolites have already been 
proven to be bioactive substances. Because of its 
wide immunomodulatory properties, DC might be 
a potential target for the ginseng and its major 
components. On the other hand, T-cadinol and 
calamenene, which are phytochemically classiﬁ  ed 
as sesquiterpene, are isolated from the black heart-
wood of Cryptomeria japonica. T-cadinol is iso-
lated from scented myrrh, which is the resin of the 
plant Commiphora guidottii Chiov., Burseraceae 
[26]. This resin is widely used in Somalia tradi-
tional medicine as remedy for treating various 
gastrointestinal disorders and diarrhea [27]. 
T-cadinol has been shown to inhibit CT (Cholera 
toxin)-induced intestinal hypersecretion in mice 
and electrically induced contractions of the isolated 
guinea pig ileum. Zygmunt et al. [28] have shown 
that T-cadinol is a calcium antagonist at high doses 
and interacts with dihydropyridine binding sites 
on the voltage-operated calcium channels. Thus, 
T-cadinol and related compounds have also phar-
macologically activity, but its immunomodulatory 
properties are still unknown. In this study, we 
investigated the ability of M1 and M4 (Fig. 1), 
endproducts of steroidal ginseng saponins metab-
olized in digestive tracts, as well as T-cadinol and 
calamenene (Fig. 1) to inﬂ  uence the differentiation 
of DC from peripheral blood monocyte.
Materials and Methods
Culture medium, reagents 
and monoclonal antibodies
The culture medium used in this study was serum-
free AIM-V medium (Life Technologies, Paisley, 
U.K.). Recombinant human IL-4 (IL-4), recombinant 
human TNF-alpha (TNF-α), recombinant human 
granulocyte-macrophage colony-stimulation factor 
(GM-CSF) and CD40-L were purchased from 
R and D Systems (Minneapolis, MN). LPS from 
Escherichia Coli was purchased from Sigma-
Aldrich (St. Louis, MO). CT was purchased from 
Boehringer Mannheim GmbH (Germany). For ﬂ  ow 
cytometry, monoclonal antibodies (mAbs) towards 
the following antigens were purchased from Becton 
Dickinson (San Jose, CA): anti-CD14-FITC, anti-
CD1a-PE, anti-CD80-PE, anti-CD83-PE, anti-
CD86-PE and HLA-DR-FITC. Endotoxin levels in 
all agents were below 1.0 EU/ml.271
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Ginseng saponins, and isolation 
of T-cadinol or calamenene from the 
Black Heartwood of C. japonica
The ginseng saponins were supplied by the Korea 
Tobacco and Ginseng Corp. (Seoul, Republic of 
Korea). The purities of the ginsenosides were 
checked by the thin-layer chromatography and 
nuclear magnetic response according to the method 
of Kawashima and Samukawa [29] and the purity 
of samples was  95%. The metabolites of the 
ginseng saponins (M1 and M4)) were prepared as 
previously described [25]. T-cadinol and calame-
nene were prepared as previously described [30]. 
The purity of T-cadinol and calamenene was 
 99%. The metabolites of the ginseng saponins 
(M1 and M4), T-cadinol and calamenene were 
dissolved in dimethylsulfoxide. The concentration 
of dimethylsulfoxide in the culture medium was 
0.1%, which had no effect upon the culture and the 
production of cytokines under the conditions used 
in this study. The endotoxin in M1, M4, T-cadinol 
and calamenene was removed using Endo Trap 5/1 
(Endotoxin removal system, Profos AG, Regens-
burg, Germany). Leading to LPS concentrations 
below the detection limit of the assay ( 0.05 EU/ml). 
LPS-depleted M1, M4, T-cadinol and calamenene 
were used for subsequent experiments.
Generation of monocytes-derived DC
All cell subsets were isolated from peripheral blood 
of normal healthy donors. PBMC were ﬁ  rst isolated 
from heparinized whole blood by Ficoll/Isopaque/
1.077 g/ml (Pharmacia, Freiburg, Germany) den-
sity gradient centrifugation (465 × g, 45 min, 
22 °C) as previously described [31]. PBMC were 
further separated into monocytes and lymphocytes 
by counterﬂ  ow centrifugation using the JE-6B-
elutriator system (Beckman Instruments Inc., Palo 
Alto, CA) [31]. The purity of CD14+ monocytes 
was always more than 90%. Monocytes were 
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Figure 1. Structures of M1, M4, T-cadinol and calamenene.272
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cultured with GM-CSF (25 ng/ml) and IL-4 
(25 ng/ml) in serum-free AIM-V medium for 
6 days. At day 6, cells ( 95% CD1a+, CD14−) 
were harvested and re-cultured in serum-free AIM-
V medium containing GM-CSF and IL-4 for 
additional 2 days with various concentrations of 
M1, M4, T-cadinol or calamenene, but with LPS 
(100 ng/ml), CT (10 μg/ml) or TNF-α (25 ng/ml). 
All subsequent tests were performed after harvest-
ing the cells at day 8 and after removing the above 
factors by extensive washing. The medium was 
replenished with cytokines every 2 days. To deter-
mine the production of IL-6, IL-10 and IL-12p70 
by M1-, M4-, T-cadinol-, calamenene-, LPS-, CT- 
or TNF-α-primed DC, DC (4 × 10
4 cell/well) were 
stimulated with CD40-L (3.0 μg/ml) for 24 h. The 
cell-free supernatants were collected and frozen at 
–20 °C until measurement of cytokines using 
enzyme-linked immunosorbent assay (ELISA).
Immunophenotype studies
Dual-Colour immunoﬂ  uorescence was performed 
using the following panel of monoclonal antibod-
ies: PE-conjugated antihuman CD1a, FITC-
conjugated antihuman CD14, PE-antihuman 
CD80, PE-antihuman CD83, PE-antihuman CD86 
and FITC-HLA-DR. Negative control was isotype-
matched with irrelevant monoclonal antibodies 
(Becton Dickinson). Cells were re-suspended in 
staining medium containing PBS, 5% BSA and 
0.1% NaN3, and then ﬁ  xed with 1% paraformal-
dehyde. Isotype controls were run in parallel. Cell 
debris was eliminated from the analysis by forward 
and side scatter gating. The samples were analyzed 
on FACSCalibur (Becton Dickinson) with Cell-
Quest software (Becton Dickinson). Ten thousand 
cells were analyzed per sample. The results were 
expressed as MFI.
Allo MLR
CD4+ naïve T cells for the allo MLR were obtained 
from allogeneic PBMC using magnetic cell sorting 
and separation of biomolecules (MACS) beads 
(Miltenyi Biotec). The purity of isolated cells was 
 95% of CD4+ naïve T cells as determined by 
ﬂ  ow cytometry using FACSCalibur. Allogeneic 
CD4+ naïve T cells (5 × 10
4 cell/well) were co-
cultured in 96-well round-bottomed culture plates 
with graded doses (2 × 10
2 to 5 × 10
4) of irradiated 
(30 Gy) DC. After 5 days, cells were pulsed with 
1 μCi [
3H]-methylthymidine per well for 16 h, then 
harvested and analyzed in a liquid scintillation 
counter.
Determination of naïve T cell 
polarization by DC
Irradiated (30 Gy) DC were co-cultured with naïve 
T cells (2.5 × 10
5 cell/200 μl) at 1:5 DC/T cell ratio 
in 96 well U-bottomed tissue culture plates (Costar, 
Cambridge, MA). Some cultures were supple-
mented with neutralizing Abs to block endogenous 
cytokines: anti-IL-12 (10 μg/ml, R and D Systems). 
On day 5, cells were washed extensively and 
expanded with fresh medium containing 10 U/ml 
of recombinant human IL-2 (IL-2) (Shionogi Phar-
maceutical Company, Osaka, Japan). One hundred 
microliters of culture supernatant was replaced 
with medium of the same concentration every 
3 days. On day 14, cells were washed, counted, 
and T cells (10
6/ml) were re-stimulated for 24 h on 
plates coated with anti-CD3 (0.2 μg/ml; BD-
Pharmingen) and anti-CD28 (2.0 μg/ml; BD-
Pharmingen). The cell-free supernatants were 
collected and frozen at –20 °C until measurement 
of cytokines using ELISA.
Intracellular cytokine staining
The intracellular cytokine concentrations of the 
harvested T cells were measured by FACS analysis 
as previously described [32]. Briefly, T cells 
(10
6/ml) were stimulated with phorbol myristate 
acetate (PMA) (10 ng/ml) and ionomycin (1 μg/ml) 
for 5 h at 37 °C in a water bath. Brefeldin A 
(10 μg/ml) was added during the last 2 h of incuba-
tion to prevent cytokine secretion. Cells were col-
lected, fixed with 1% paraformaldehyde, 
permeabilized with a commercial solution 
(BD-Pharmingen), and stained with FITC-labelled 
anti-IFN-γ (IgG2a) and PE-labelled anti-IL-4 (IgG1) 
mAbs. The samples were analyzed on a FACS-
Calibur with CellQuest software. Ten thousand 
cells were analyzed per sample.
Transmigration assay
Migration of DC induced by macrophage inﬂ  am-
matory protein (MIP)-3β was measured using a 
double chamber system as previously described 
[33]. Brieﬂ  y, Transwells of 5 μm pore size ﬁ  lters 
(Kurabo, Osaka, Japan) were used. MIP-3β was 
seeded at concentrations of 0.1, 1.0, 10 and 100 nM 
diluted with 500 μl of culture medium in the lower 273
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chambers of 24-well plates. DC (1 × 10
5/100 μl) 
were then added to the upper chambers of the 
Transwell plates. Transwell cultures were main-
tained for 5 h in 5% CO2 at 37 °C, and DC migrated 
from the upper wells were counted using a Colter 
Counter. The results were expressed as net migra-
tion percent calculated as:(the number of cells that 
migrated into the lower chamber containing 
chemokine-number of cells that migrated in 
medium alone)/total number of cells loaded in the 
upper chamber × 100.
Measurement of intracellular Ca
2+ 
concentration
The determination of intracellular Ca
2+ ([Ca
2+]i) 
concentration was carried out as previously 
described [34]. Brieﬂ  y, 2 × 10
6 cells were incu-
bated for 45 min at 37 °C with 2.5 μM of fura-2/AM 
in 5 mM HEPES buffer containing 140 mM NaCl, 
4 mM KCl, 1.25 mM CaCl2, 1 mM Na2HPO4, 
1 mM MgCl2, 11 mM gulcose and 0.1% bovine 
serum albumin at pH 7.4. Samples of the cell sus-
pension were placed in the cuvette. Then, MIP-3ß 
(100 nM) was added with a microsyringe directly 
into the cuvette, without interrupting the recording. 
[Ca
2+]i was monitored with a CAF110 spectroﬂ  uo-
rimeter (λex = 340 nm and 380 nm, λem = 510 nm; 
JASCO, Tokyo).
Reverse transcription-polymerase 
chain reaction (RT-PCR) for CCR7
Total RNA was extracted from 1–2 × 10
6 DC using 
an RNeasy Mini Kit (Qiagen, Germany). The 
cDNA synthesized from total RNA by Moloney 
murin leukaemia virus reverse transcriptase 
(Stratagene, Austin, TX, U.S.A.) was subjected to 
RT-PCR using 30 cycles at 94 °C for 0.5 min, 
57.5 °C for 1 min, and 72 °C for 1 min for CCR7 
(Takara, Tokyo, Japan). The sense and anti-sense 
oligonucleotide primers for CCR7 were 5’-CGC-
GTCCTTCTCATCAGCAA-3’ and 5’-GTCCC-
GACAGGAAGACCACT-3’, respectively. PCR 
products were identiﬁ  ed by electrophoresis on 2% 
agarose gels that were photographed.
Cytotoxic T-lymphocyte (CTL) assay
Details of the method used in this assay have been 
previously described [35]. Brieﬂ  y, DC (5 × 10
5) 
cultured from monocytes of HLA-A24+ donors 
were loaded with 10 μM Epstein-Barr virus 
(EBV)-derived peptide (TYGPVFMCL) for 2 h at 
37 °C in 5% CO2. EBV-derived peptide can bind 
to HLA-A2402 as reported by Lee et al. [36]. In 
24 well plates, autologous CD8+T cells were co-
cultured as effector cells at a ratio of 2:1 with DC 
in 2 ml of medium (RPMI 1640:AIM-V = 1:1) 
containing 10% FCS (Sigma; St. Louis, MO), 1% 
penicillin-streptomycin, and 0.1 mM nonessential 
amino acid supplemented with 100 U/ml IL-2 for 
10 days; half the medium was changed every 3 days. 
BEC-2 cell lines (HLA-A2402) and BamB-2 cell 
lines (HLA-A1/A26) were generated from EBV-
transformed B-lymphoblastoid cell lines which 
were generated from an EBV + healthy donor. The 
BEC-2 cells and Bamb-2 cells as target cells were 
loaded at a concentration of 1 × 10
6 cells/ml with 
10 μM EBV peptide and incubated for 2 h at 37 °C 
in 5% CO2. Effector cells were co-cultured with 
target cells at effector-to-target ratios of 2:1, 10:1 
and 20:1 in 96 well round-bottomed culture plates 
(total volume of 200 μl) in duplicate. After overnight 
incubation at 37 °C in 5% CO2, IFN-γ-concentration 
of the supernatant was determined by ELISA.
51Cr release assay
Details of the methods used in this assay have been 
previously described [37]. Brieﬂ  y, effector cells 
were incubated with 
51Cr labelled target cells 
(1 × 10
4) at various effecor-to- target cell ratios for 
6 h, followed by supernatant harvesting for measur-
ing radioactivity using as automatic γ counter. This 
assay was done in triplicate.
Statistical analysis
Statistical analysis of the results was performed by 
ANOVA. Differences were considered statistically 
signiﬁ  cant when p value were less than 0.05.
Results
Phenotype and endocytic capacity
To study the direct effects of M1, M4, T-cadinol 
and calamenene on the maturation of sentinel DC 
into effector DC, human monocytes-derived DC 
were cultured with M1, M4, T-cadinol or calam-
enene. Human monocytes were cultured with GM-
CSF and IL-4 for 6 days under standard conditions, 
followed by another 2 days in the presence of 
various concentrations of M1, M4, T-cadinol or 
calamenene. LPS, CT and TNF-α were used as a 274
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positive control. The resulting populations of DC 
were analyzed by ﬂ  ow cytometry. As shown in 
Table 1, the expression levels of CD1a, CD80, 
CD83, CD86 and HLA-DR as expressed by MFI 
on M1-primed DC, M4-primed DC, T-cadinol-
primed DC and calamenene-primed DC were 
enhanced in a dose-dependent manner. The expres-
sion level of CD14 as expressed by MFI on day 8 
was low or undetectable. Viability of cells at 20 μM 
of M1 and M4, and at 10 μM of T-cadinol and 
calamenene was  95%. From these results, the 
concentrations of M1 and M4 were used at 20 μM, 
and of T-cadinol and calamenene at 10 μM, respec-
tively. The expression levels of CD1a, CD 80, 
CD83, CD86 and HLA-DR as expressed by MFI 
on LPS-primed DC, CT-primed DC, and TNF-α-
primed DC were also enhanced (Table1). This 
pattern was identical with that of M1-primed 
DC, M4-primed DC, T-cadinol-primed DC or 
calamenene-primed DC. As control, immature DC 
were generated by cultivating human monocytes 
with GM-CSF and IL-4 for 8 days. This differen-
tiation process is accompanied by changes in the 
expression of several surface markers as detailed 
in Table 1. Upon maturation and concomitant with 
an increase in Ag presenting function, DC have a 
reduced capacity for Ag capture via endocytic 
activity. To determine whether mechanisms of Ag 
capture could also be modulated by M1, M4, 
T-cadinol or calamenene, the endocytic activity 
was measured in immature DC, M1-primed DC, 
M4-primed DC, T-cadinol-primed DC or 
calamenene-primed DC. FITC-dextran uptake 
mediated by M1-primed DC, M4-primed DC, 
T-cadinol-primed DC, calamenene-primed DC, 
LPS-primed DC, CT-primed or TNF-α-primed DC 
was signiﬁ  cantly lower than immature DC (data 
not shown). These results suggested that DC dif-
ferentiated by M1, M4, T-cadinol or calamenene 
down-regulated their endocytic capacity.
Table 1. Comparison phenotype of DC cultured with M1, M2, T-cadinol and Calamenene on day 8.
CD1a CD80 CD83 CD86 HLA-DR
M1
1 μM 62 ± 19 109 ± 13 48 ± 13 398 ± 12 989 ± 86
10 μM 198 ± 25 148 ± 7 62 ± 18 458 ± 35 1081 ± 63
20 μM 183 ± 12 203 ± 14 82 ± 12 560 ± 34 1190 ± 132
M4
1 μM8 1   ± 32 102 ± 6 48 ± 4 348 ± 38 1056 ± 85
10 μM 122 ± 18 148 ± 66 9  ± 9 465 ± 15 1189 ± 142
20 μM 212 ± 40 208 ± 6 106 ± 32 592 ± 48 1334 ± 105
T-cadinal
0.1 μM 65 ± 18 110 ± 28 32 ± 12 331 ± 38 834 ± 76
1.0 μM 157 ± 21 159 ± 29 56 ± 18 452 ± 36 921 ± 98
10 μM 183 ± 22 208 ± 32 81 ± 19 586 ± 41 1058 ± 121
Calamenene
0.1 μM 78 ± 19 105 ± 28 35 ± 13 335 ± 39 956 ± 108
1.0 μM 167 ± 29 158 ± 31 63 ± 16 443 ± 41 1168 ± 231
10 μM 210 ± 31 221 ± 33 109 ± 21 601 ± 38 1267 ± 298
LPS(100 ng/ml) 201 ± 20 232 ± 36 106 ± 20 622 ± 41 1308 ± 299
CT(10 μg/ml) 209 ± 18 228 ± 32 68 ± 8 680 ± 82 1412 ± 389
TNF-α(25 ng/ml) 196 ± 48 209 ± 9 82 ± 18 620 ± 43 1395 ± 125
immature DC 80 ± 10 48 ± 49  ± 2 334 ± 28 665 ± 98
Monocyte 5 ± 15  ± 26  ± 2 11 ± 2 56 ± 3
Data are the mean ± S.E.M. of ﬁ  ve independent experiment.275
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IL-12 p70, IL-6 and IL-10 release
by activated DC
Because the level of IL-12 production by DC is 
a major factor driving the development of Th1 
cells, we studied the influence of M1, M4, 
T-cadinol or calamenene on IL-12 production by 
DC. We measured IL-12p70 production in imma-
ture DC and in DC matured for 2 days in the 
presence of the above factors after stimulation 
by CD40-L for 24 h. The production of IL-12p70 
by M1-primed DC, M4-primed DC, T-cadinol-
primed DC and calamenene-primed DC was more 
augmented than that of LPS-primed DC (Fig. 2A). 
In contrast, the production of IL-12p70 by CT-
primed DC or TNF-α-primed DC was low or just 
detectable (Fig. 2A). IL-6 is an important medi-
ator of a wide range of biologic activities that 
play a critical role in the induction of proinﬂ  am-
matory and immune responses. Moreover, IL-10 
is a pleiotropic cytokine known to have inhibitory 
effects on the accessory functions of DC and 
appears to play a central role in preventing overly 
pathological Th1 or Th2 responses in a variety 
of settings. Therefore, we also studied the pro-
duction of IL-6 and IL-10 by DC differentiated 
under the inﬂ  uence of the above factors. The 
production of IL-6 by M1-primed DC, M4-
primed DC and calamenene-primed DC was 
higher than that of LPS-primed DC (Fig. 2B). On 
the other hand, the production of IL-10 by M1-
primed DC, M4-primed DC, T-cadinol-primed 
DC, calamenene-primed DC, LPS-primed DC 
and TNF-α-primed DC was low (Fig. 2C). Major 
enhancements of IL-10 production were caused 
by CT-primed DC (Fig. 2C). The production of 
IL-12p70, IL-6 and IL-10 was lower in immature 
DC (Fig. 2A, B and C).
Immunostimulatory capacity
in an allo MLR
We observed that M1-primed DC, M4-primed DC, 
T-cadinol-primed DC and calamenene-primed DC 
expressed increased levels of Ag-presenting and 
the expression levels of CD1a, CD80, CD83, CD86 
and HLA-DR as expressed by MFI. Therefore, we 
next compared the capacity of M1-primed DC, 
M4-primed DC, T-cadinol-primed DC, calamenene-
primed DC, LPS-primed DC, CT-primed DC or 
TNF-α-primed DC to stimulate T cells in an allo 
MLR. M4-primed DC showed higher stimulatory 
efﬁ  ciency in an allo MLR than LPS-primed DC 
(Fig. 3), CT-primed DC or TNF-α-primed DC 
(data not shown). On the other hand, T cell stimu-
latory capacity of immature DC in an allo MLR 
was low (Fig. 3).
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Terpenoids-primed DC promote 
the differentiation of naïve T cells 
into Th1 cells at 1:5 DC/T cell ratio
We next evaluated the nature of primary 
allogeneic T cell responses stimulated by M1-
primed DC, M4-primed DC, T-cadinol-primed 
DC and calamenene-primed DC. Allogeneic M1-
primed DC, M4-primed DC, T-cadinol-primed 
DC or calamenene-primed DC co-cultured with 
naïve T cells at 1:5 DC/T cell ratio secreted 
sizeable amounts of IFN-γ (Fig. 4A), but little 
IL-4 (Fig. 4B). Similar results were obtained with 
LPS-primed DC and TNF-α-primed DC (Fig. 4A 
and B). The production of IFN-γ by naïve T cells 
co-cultured with M4-primed DC, T-cadinol-
primed DC or calamenene-primed DC was higher 
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Figure 2. Cytokine production by CD40-L-stimulated DC.
DC were generated by stimulating immature DC with M1 (20 μM), M4 (20 μM), T-cadinol (10 μM), calamenene (10 μM), LPS (100 ng/ml), 
CT (10 μg/ml) or TNF-α (25 ng/ml). Cells (4 × 10
4 cell/well) were stimulated with the CD40-L (3.0 μg/ml) for 24 h. After 24 h, the production 
of IL-12p70 (A), IL-6 (B) and IL-10 (C) was measured by ELISA in culture supernatants. Data are the mean ± S.E.M. of ﬁ  ve independent 
experiments. *P   0.05 compared with LPS-primed DC.277
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than that of LPS-primed DC (Fig. 4A). Naïve 
T cells co-cultured with M1-primed DC, M4-
primed DC, T-cadinol-primed DC, calamenene-
primed DC, LPS-primed DC or TNF-α-primed 
DC turned into typical Th1 cells, which produced 
large quantities of IFN-γ and released small 
amounts of IL-4. In contrast, naïve T cells co-
cultured with DC differentiated with CT turned 
into Th2 cells producing large quantities of IL-4 
and releasing small amounts of IFN-γ (Fig. 4A 
and B). These responses were conﬁ  rmed by ﬂ  ow 
cytometry (Fig. 5). On the other hand, naïve 
T cells co-cultured with immature DC secreted 
signiﬁ  cantly less IFN-γ and IL-4 (Fig. 4A and B). 
To analyze the contribution of DC-derived IL-12 
on the development of Th1 cells, we tested the 
effect of a neutralizing anti-IL12 mAb in co-
culture experiments, where naïve T cells were 
co-cultured with M1-primed DC, M4-primed DC, 
T-cadinol-primed DC or calamenene-primed DC. 
In M1-primed DC, M4-primed DC, T-cadinol-
primed DC and calamenene-primed DC, 
neutralization of IL-12 increased the development 
of IL-4 producing T cells and dramatically 
decreased the development of IFN-γ producing 
T cells (Fig. 6A and B). Similar results were 
obtained with LPS-primed DC (Fig. 6A and B). 
In contrast, the isotype control had no effect 
(Fig. 6A and B).
Terpenoids-primed DC are capable
of migration in vitro
Because during the maturation process, DC up-
regulate the synthesis of constitutive chemokines 
and the CCR7 receptor, we measured the migration 
of M1-primed DC, M4-primed DC, T-cadinol-
primed DC, calamenene-primed DC, or LPS-
primed DC in response to MIP-3β in vitro. 
T-cadinol-primed DC and calamenene-primed DC 
had a higher migration response to MIP-3β than 
LPS-primed DC (Fig. 7A). Similar results were 
obtained with intracellular Ca
2+ mobilization to 
MIP-3β (Fig. 7B). Migration response and intracel-
lular Ca
2+ mobilization to MIP-3β were observed 
with CT-primed DC and TNF-α-primed DC (data 
not shown). On the other hand, migration response 
and intracellular Ca
2+ mobilization to MIP-3β in 
immature DC were low or just detectable (Fig. 7A 
and B). Additionally, RT-PCR conﬁ  rmed the up-
regulation of the CCR7 receptor in T-cadinol-
primed DC and calamenene-primed DC (Fig. 7C). 
Similar results were obtained with M1-primed DC 
and M4-primed DC (data not shown).
Figure 3. Allogeneic T cell stimulatory capacity of DC differentiated with M1, M4, T-cadinol, calamenene or LPS.
CD4+naïve T cells (5 × 10
4 cell/well) were co-cultured with graded doses of M1-, M4-, T-cadinol-, calamenene- or LPS-primed DC, and on 
day 5, [
3H]-methylthymidine was added 16 h before measurement of the proliferation response. Data are the mean cpm ± S.E.M. of ﬁ  ve 
independent experiments. *P   0.05 compared with immature DC; #P   0.05 compared with LPS-primed DC.
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DC cultured with M4 augment 
the cytotoxicity of CD8+T cells 
against BEC-2 target cells
We compared the CTL responses of autologus 
CD8+T cells supported DC differentiated with M1, 
M4 or TNF-α. The production of IFN-γ by M4-
primed DC was strongly augmented (Fig. 8A). The 
production of IFN-γ on M1-primed DC was more 
augmented than that of immature DC (Fig. 8A). 
The production of IFN-γ was dependent on the 
increased number of effector cells. Similar results 
were obtained with 
51Cr release assay to measure 
speciﬁ  c lysis of target cells (Fig. 8B), On the other 
hand, the production of IFN-γ and 
51Cr release was 
not observed when BamB2 (HLA-A24-) was used 
as a target cell (negative control) (Fig. 8A and B).
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Figure 4. Measurements of IFN-γ and IL-4 by ELISA in supernatant of naïve T cells stimulated by M1-, M4-, T-cadinol-, calamenene-, LPS-, 
CT-, or TNF-α-primed DC. Allogeneic DC were co-cultured for 5 days with naïve T cells at 1:5 DC/T cell ratio. After 9 days of expansion in 
IL-2, T cells were counted and re-stimulated for 24 h on plates coated with anti-CD3/CD28. IFN-γ (A) and IL-4 (B) were measured by ELISA 
in culture supernatants. Data are the mean ± S.E.M. of ﬁ  ve independent experiments. *P   0.05 compared with LPS-primed DC.
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Discussion
The present study was performed in order to inves-
tigate whether M1 and M4, end products of steroi-
dal ginseng saponins metabolized in digestive 
tracts, as well as T-cadinol and calamenene can 
change the phenotype and function associated with 
DC differentiation from human monocytes in vitro. 
Here, we demonstrate that culture of immature DC 
with M1, M4, T-cadinol or calamenene increase 
cell surface expression of CD1a, CD80, CD83, 
CD86 and HLA-DR, while decreasing endocytic 
activity, resulted in cells with a phenotype charac-
terized by efﬁ  cient Ag-presentation and costimula-
tory capacity of mature DC. Functionally, 
M1-primed DC, M4-primed DC, T-cadinol-primed 
DC or calamenene-primed DC have enhanced 
primary allogeneic T cell stimulatory activity in 
an allo MLR.
The differentiation of monocytes into DC has a 
critical impact on the immune response. DC inter-
action with naïve T cells plays a key role in primary 
immune responses [1, 3] and the interaction of 
T cells with DC is crucial for directing T cell dif-
ferentiation towards the Th1, Th2 or Th17 type [18, 
38]. The balance of Th1 and Th2 cells is character-
ized by different cytokine production and homing 
capacity [10–12], and strongly depends on the 
model system used [6, 7]. M1-primed DC, 
M4-primed DC, T-cadinol-primed DC or 
calamenene-primed DC polarized into Th1 via high 
IL-12p70 secretion upon CD40-L (T cells engage-
ment) stimulation and demonstrated that the pro-
duction of IFN-γ by naïve T cells co-cultured with 
M1-primed DC, M4-primed DC, T-cadinol-primed 
DC or calamenene-primed DC was affected by the 
presence of a neutralizing anti-IL-12 mAb. The 
reduced induction of IFN-γ after incubation with 
anti-IL-12 mAb indicates that IFN-γ induction is 
largely dependent on endogenous IL-12. Cytokines 
are most important in the environment response, 
and IL-12 is essential for inducing Th1 polarization 
[39, 40]. IL-12 has anti-tumor effects of its own for 
which it is currently under clinical evaluation [39]. 
Therefore, the ﬁ  nding that M1, M4, T-cadinol or 
calamenene can increase IL-12p70 secretion by DC 
is of major interest, although the rational for ginseng 
saponins use in the treatment of cancer is still 
unclear. Although the down-regulation of NF-κB 
and AP-1 transcription factors has often been 
hypothesized to explain the anti-cancer effects of 
ginseng saponins, there is some evidence that these 
mechanisms do not clearly account for the anti-
cancer effect of ginseng saponins [41]. Wakabayashi 
et al. [42] have demonstrated that the induction of 
an in vivo anti-metastatic effect by oral administra-
tion of ginsenosides may be primarily meditated 
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by their metabolic component M1 and M4. More-
over, Scaglione et al. [43] have investigated immu-
nomodulatory effects of ginseng extract G115 and 
they have indicated an earlier induction immune 
response mediated by their G115 preparation than 
by the aqueous extract. The Th1 cells that produce 
IFN-γ have been shown to exert a powerful anti-
tumor effect, whereas a weak Th1 or a Th2 proﬁ  le 
may have an opposite effect, that is, down-
regulation of innate and acquired anti-tumor immu-
nity [44]. The corollary of these observations is that a 
Th1 proﬁ  le may be protective against tumor growth 
and dissemination. Moreover, a recent study 
describes mycoplasma as another pathogen 
involved in DC activation, resulting in release of 
IL-12, TNF-α and IL-6 [44]. M1-primed DC, M4-
primed DC, T-cadinol-primed DC or calamenene-
primed DC provide stronger costimulatory signals 
and/or the proinﬂ  ammatory cytokines needed for 
T cell activation and Th1 development. Therefore, 
it suggests that the effects of M1 or M4 on the 
production of IL-12p70 by DC and strengthening 
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of the Th1 response by naïve T cells might, at least 
in part, contribute to a potential anti-tumor effect 
of M1 or M4. Ginseng may be the most commonly 
used diet supplement in the world. It is unlikely that 
healthy individual develop harmful self-destructive 
Th1 response by ginseng, because there are few the 
content of ginseng in diet supplement. It seems that 
TNF-α-primed DC drive the differentiation of naïve 
T cells towards Th1 via an unknown factor, because 
TNF-α-primed DC did not increase the IL-12 
production upon CD40 ligation.
In contrast, CT-primed DC induced naïve T cells 
showed a shift towards Th2 effector cell. CT is a 
powerful mucosal adjuvant that ampliﬁ  es B cell 
and T cell responses to mucosally co-administered 
antigens, stimulating predominant Th2-type 
responses [45, 46]. Gagliardi et al. [48] have dem-
onstrated that CT-treated DC induce Th2 polariza-
tion of naïve T cells in vitro is very likely due to 
the lack of IL-12 production by CT-treated DC and 
may be independent of IL-4. We showed that the 
production of IL-12 by CT-primed DC that were 
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stimulated CD40-L was low or detectable. 
Therefore, it suggests that the involvement of these 
cells in the innate responses to Th1 response-
inducing pathogens during the period preceding 
the initiation of adaptive immunity can create an 
environment rich in IL-12, which promotes the 
production of IFN-γ and the outgrowth of Th1 cells. 
It has been demonstrated that immune balance 
controlled by cytokines such as IL-10 and IL-12 
plays an important role in immune regulation, 
including anti-tumor immunity [16]. Our results 
showed that M1-primed DC, M4-primed DC, 
T-cadinol-primed DC and calamenene-primed DC 
have a decreased ability to produce IL-10, and that 
these DC have the potency to induce Th1 cells. In 
contrast, the production of IL-10 by CT-primed 
DC was high and these DC polarized into Th2 cells. 
Therefore, it seems likely that the development of 
the Th1 response is controlled, at least partly, by 
IL-10 and IL-12 and may be a crucial polarizing 
factor for Th1 response development.
One result of DC maturation and activation 
demonstrate increased motility and a potential to 
propensity to migrate towards lymphoid organs. 
During the maturation process, DC down-regulate 
the expression of inﬂ  ammatory chemokines and 
their receptors and up-regulate the synthesis of 
constitutive chemokines and the chemokine 
receptor CCR7. We found that M1-primed DC, 
M4-primed DC, T-cadinol-primed DC and 
calamenene-primed DC had high migration, high 
calcium mobilization in response to MIP-3β and 
up-regulated the expression of CCR7, suggesting 
that M1-primed DC, M4-primed DC, T-cadinol-
primed DC and calamenene-primed DC are likely 
to be mature DC that have the potential to migrate 
in vivo. In most clinical trials using DC-based 
immunotherapy, immature monocytes-derived DC 
pulsed with tumor antigen peptides were used. 
However, recent observation suggests that mature 
DC could be a better anti-tumor adjuvant [49]. 
Although the role of chemokine receptor for 
clinical application are not known yet, M1, M4, 
T-cadinol and calamenene appear to be a good 
factor to induce DC maturation, or even better in 
some respect, for the use in clinical DC therapy to 
induce strong Th1-type immune responses. The 
concentration of terpenoids in this in vitro used 
10 μM, but this concentration achievable in any in 
vivo are still not clear. The experiment of in 
vivo on terpenoids-primed DC requires further 
investigation.
A        B        C
Figure 7. Chemotaxis and intracellular Ca
2+ mobilization in response 
to MIP-3β by M1-, M4-, T-cadinol-, calamenene- or LPS-primed DC.
(A) M1-, M4-, T-cadinol-, calamenene- or LPS-primed DC were 
prepared and recovered, and their migratory abilities in response to 
MIP-3β (0.1–100 nM) were determined in vitro. Data are the mean ± 
S.E.M. of ﬁ  ve independent experiments. *P   0.05 compared with 
LPS-primed DC. (B) [Ca
2+]i mobilization of M1-, M4-, T-cadinol-, 
calamenene- or LPS-primed DC induced by MIP-3β (100 nM). Cells 
were loaded with fura-2/AM and the ratio of ﬂ  uorescence at 340 nm 
and 380 nm was monitor. Data are the mean ± S.E.M. of ﬁ  ve 
independent experiments. *P   0.05 compared with LPS-primed 
DC. (C) cDNA prepared from T-cadinol-primed DC and calamenene-
primed DC was subjected to RT-PCR-speciﬁ  c primer. The PCR 
products (573 bp) were fractionated on 2% agarose gels and 
visualized by ethidium bromide staining. a: T-cadinol-primed DC, 
b: calamenene-primed DC, c: immature DC.
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Figure 8. Autologus CD8+T cells with DC showed higher cytolytic activity against BEC-2 target cells at a high effector-to-target ratio than 
against Bamb-2 target cells. Autologous CD8+T cells were co-cultured with M1-, M4- or TNF-α-primed DC loaded with EBV-derived peptide, 
expanded with 100 U/ml IL-2, and on day 10, re-stimulated with BEC-2 or Bamb-2 target cells at various effector-to-target ratios. After 
overnight culture, the IFN-γ concentration in the supernatant was measured by ELISA (A), and speciﬁ  c lysis was measured by 
51Cr release 
assay (B). Data are the mean ± S.E.M. of ﬁ  ve independent experiments. *P   0.05 compared with immature DC.
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Antitumor immunity has classically been mea-
sured by the quantity of tumor-antigen-speciﬁ  c 
CD8+ T cells [50]. Immunotherapy is based on this 
mechanism. In this context, it is important to know 
whether M1-primed DC or M4-primed DC 
enhanced speciﬁ  c CTL responses. We evaluated 
the CTL response to examine the possible clinical 
application of our culture system, since DC dif-
ferentiated with M1 or M4 induced a signiﬁ  cant 
differentiation of naïve T cells towards a helper 
T cells type I response. As expected from their 
Th1-polarizing effect, the DC differentiated with 
M4 induced a stronger CTL response than imma-
ture DC and TNF-α-primed DC. Therefore, we are 
expecting the possibility of a clinical application. 
The effects of T-cadinol and calamenene in the 
CTL response are not known yet. However, we 
expect to obtain similar results with M1 and M4, 
because T-cadinol-primed DC and calamenene-
primed DC enhanced the differentiation of naïve 
T cells towards the Th1 type. Recent studies have 
demonstrated that the ginseng saponins orally 
administrated are promptly metabolized in the 
digestive tract and absorbed into the circulation 
[23, 24]. The major metabolites of the proto-
panaxidiol saponin are M1, M2, M3 and M5, and 
those of the protopanaxatriol are M4 and M11 
(Fig. 1). Finally, the protopanaxadiol and the pro-
topanaxatriol saponins and their intermediate 
metabolites (M2, M3, M5 and M11) are converted 
into the end products M1 protopanaxadiols and M4 
protopanaxatriol, respectively. There is the pos-
sibility that the metabolites are the actual active 
substances of the ginseng saponins, particularly 
M1 and M4, in vivo.
Conclusion
This is ﬁ  rst study on the effect of terpenoids, e.g. 
ginseng saponins on human monocytes-derived 
DC giving new insights into the action of 
terpenoids. M1, M4, T-cadinol and calamenene 
potentially regulate differentiation of DC from 
human monocytes in combination with GM-CSF 
and IL-4 in vitro. Moreover, DC differentiated with 
M1, M4, T-cadinol or calamenene enhance the 
differentiation of naïve T cells towards the Th1 
type depending on IL-12 secretion. M-4-primed 
DC produces a stronger CTL response. Although 
the molecular events leading to the effects of M1, 
M4, T-cadinol and calamenene on DC function 
remain to be resolved, DC appear to be potential 
targets of M1, M4, T-cadinol and calamenene. 
Further understanding of the mechanisms by which 
M1, M4, T-cadinol and calamenene modulate DC 
function may lead to the development of effective 
immunotherapy for cancer.
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